XyloCor Therapeutics logo

XyloCor Therapeutics

Malvern, PA

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

xylocor.com

Company Details

Founded

2013

Employees

Between 10 - 50 employees

Raised

$107,100,000

Headquarters Location

Malvern, PA

Public

No

Acquired

No

CEO

Albert GianchettiAlbert Gianchetti

Founders

Todd Rosengart
Todd Rosengart
Ronald Crystal
Ronald Crystal

Company Collections

These are collections XyloCor Therapeutics is a part of. Click on the collection name to view similar companies.

XyloCor Therapeutics' Industries